Grid Therapeutics is an emerging clinical stage biotechnology company located in Durham, North Carolina. We have made a commitment to our patients and families to develop better and safer therapeutic antibodies for cancer. Grid has a unique and innovative platform to discover human-derived antibodies against novel tumor-specific targets, and can rapidly translate these findings into clinical practice. The Management Team was assembled to rapidly advance these assets to the clinic and have the skillsets and experience to deliver a unique portfolio in the immune-oncology space. The Board of Directors has a deep understanding of the current oncology landscape and is poised to support the Management Team deliver an efficient and impactful development plan. The Advisors and Consultants give context and insight to a wide range of topics such as clinical practice, groundbreaking laboratory techniques, manufacturing, and corporate governance.

Management Team

Edward (Ned) F. Patz,
Jr., MD, Chief Executive Officer

Read Full Bio
Thomas L. Patz,
JD, Chief Operating Officer

Read Full Bio
Ryan Dackor,
Ph.D., Director, Clinical Operations

Read Full Bio